Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04678947 · ClinicalTrials.gov registry record · NA

The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children

A NA study, sponsored by Washington University School of Medicine.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT04678947 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04678947, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

In this pilot study, the Baxter Retching Faces (BARF) Scale will be used to assess chemotherapy induced nausea and vomiting (CINV) in the pediatric cancer population during chemotherapy admissions, and the corresponding administration of anti-emetic medications will be reviewed.

Interventions

  • BEHAVIORAL Baxter Retching Faces (BARF) scale

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-03-17
Est. Completion 2021-03-25
Phase NA

What the Registry Record Tells You About NCT04678947

The ClinicalTrials.gov registry entry for NCT04678947 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Baxter Retching Faces (BARF) scale is the first listed.

NCT04678947 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04678947 about?

NCT04678947 is a clinical study titled "The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children". In this pilot study, the Baxter Retching Faces (BARF) Scale will be used to assess chemotherapy induced nausea and vomiting (CINV) in the pediatric cancer population during chemotherapy admissions, and the corresponding administration of anti-emetic medications will be reviewed.

What is the current status of trial NCT04678947?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-03-17. Estimated completion is 2021-03-25.

What interventions are being tested in trial NCT04678947?

The interventions under investigation include: Baxter Retching Faces (BARF) scale (BEHAVIORAL).

Who is sponsoring clinical trial NCT04678947?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.